Clinical Trials Directory

Trials / Completed

CompletedNCT02298049

An fMRI Study of Satiation in Healthy Volunteers.

Satiation Attenuates BOLD Activity in Brain Regions Involved in Reward and Increases Activity in an Inhibitory Control Area: an fMRI Study in Healthy Volunteers.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
16 (actual)
Sponsor
University of Birmingham · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

To our knowledge no study has assessed the effects of a meal on neural responses to food cues and compared this with a condition simulating natural inter-meal hunger levels. This is important, as the existing literature often compares the effect of fasting to satiation, which may not reflect typical appetite processes. Thus, the purpose of this research was to examine the effect of a satiating lunch compared to a normal pre-meal state on blood oxygen level dependent (BOLD) activity in the human brain, as measured using functional magnetic resonance imaging (fMRI).

Detailed description

We hypothesized that satiation would be associated with decreased brain activity across brain regions involved in both appetite and reward such as ventromedial prefrontal cortex, orbitofrontal cortex, ventral striatum, hypothalamus, insula, amygdala and hippocampus. 16 healthy participants (8 males) were scanned on two separate test days, before and after eating a meal to satiation, or after not eating for 4 hours (satiated vs. pre-meal). fMRI BOLD signals to the sight and/or taste of the stimuli were recorded. Participants were given questionnaires to complete about their mood state and appetite before and after all scans.

Conditions

Interventions

TypeNameDescription
OTHERSatiated / Pre-mealAll participants were scanned before and after not being fed (pre-meal), and before and after being given a satiating lunch (satiated).
DEVICEMRI

Timeline

Start date
2010-07-01
Primary completion
2010-12-01
Completion
2010-12-01
First posted
2014-11-21
Last updated
2014-11-21

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02298049. Inclusion in this directory is not an endorsement.